Alnylam Pharmaceuticals, Inc. financial data

Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 291 % -10.9%
Quick Ratio 7.55 % -38.9%
Debt-to-equity -13.3K % -806%
Return On Equity 905 % +442%
Return On Assets -6.83 % +43.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 129M shares +2.79%
Common Stock, Shares, Outstanding 129M shares +2.78%
Entity Public Float 31B USD +31%
Common Stock, Value, Issued 1.29M USD +2.7%
Weighted Average Number of Shares Outstanding, Basic 128M shares +2.2%
Weighted Average Number of Shares Outstanding, Diluted 128M shares +2.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.25B USD +23%
Research and Development Expense 1.13B USD +12.1%
Costs and Expenses 2.43B USD +14.9%
Operating Income (Loss) -177M USD +37.3%
Nonoperating Income (Expense) -200M USD -32.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -377M USD +13%
Income Tax Expense (Benefit) -99.2M USD -1575%
Net Income (Loss) Attributable to Parent -278M USD +36.8%
Earnings Per Share, Basic -2.18 USD/shares +38.1%
Earnings Per Share, Diluted -2.18 USD/shares +38.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 966M USD +18.9%
Accounts Receivable, after Allowance for Credit Loss, Current 405M USD +23.7%
Inventory, Net 78.5M USD -11.9%
Assets, Current 3.3B USD +10.5%
Deferred Income Tax Assets, Net 117M USD +1057%
Property, Plant and Equipment, Net 503M USD -4.42%
Operating Lease, Right-of-Use Asset 191M USD -4.3%
Other Assets, Noncurrent 65.3M USD +5.51%
Assets 4.24B USD +10.7%
Accounts Payable, Current 88.4M USD +59.3%
Employee-related Liabilities, Current 214M USD +75.5%
Accrued Liabilities, Current 887M USD +24.5%
Contract with Customer, Liability, Current 55.5M USD -46%
Liabilities, Current 1.19B USD +22.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 230M USD -5.58%
Other Liabilities, Noncurrent 398M USD +29.1%
Liabilities 4.17B USD +3.02%
Accumulated Other Comprehensive Income (Loss), Net of Tax -34.5M USD -47.7%
Retained Earnings (Accumulated Deficit) -7.29B USD -3.97%
Stockholders' Equity Attributable to Parent 67.1M USD
Liabilities and Equity 4.24B USD +10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -81.5M USD +51%
Net Cash Provided by (Used in) Financing Activities 28.9M USD -37.7%
Net Cash Provided by (Used in) Investing Activities -67.6M USD +11.3%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 129M shares +2.78%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -130M USD +33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 969M USD +18.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 30.9M USD +122%
Deferred Tax Assets, Valuation Allowance 2.79B USD -1.01%
Deferred Tax Assets, Gross 2.97B USD +2.43%
Operating Lease, Liability 271M USD -4.63%
Payments to Acquire Property, Plant, and Equipment 13M USD -6.61%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -289M USD +30.9%
Lessee, Operating Lease, Liability, to be Paid 384M USD -8.03%
Property, Plant and Equipment, Gross 773M USD +3.21%
Operating Lease, Liability, Current 41.9M USD +0.91%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.2M USD -0.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 43.4M USD -0.47%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 113M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41.6M USD +2.32%
Deferred Tax Assets, Operating Loss Carryforwards 883M USD +9.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 53.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 40.5M USD +3.89%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 272M USD +22.7%
Interest Expense 128M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%